Back
H&R Block, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
47
HRB
H&R Block, Inc.
Last Price:
$43.59
Seasonality Move:
1.64%
Sell
39
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.25
Seasonality Move:
-0.81%
Sell
47
H&R Block, Inc. (HRB)
is a Sell
Is H&R Block, Inc. a Buy, Sell or Hold?
-
The current H&R Block, Inc. [HRB] share price is $43.58. The Score for HRB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
HRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $36.31. The Score for ZBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRB Stock Price Chart
What is H&R Block, Inc.'s stock price today?
-
The H&R Block, Inc. share price today is $43.58The current trend is relatively stagnant and HRB is experiencing slight buying pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $36.31The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
HRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 48.3 | Sell |
| Chaikin Money Flow: | 393634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.99 - 43.61) | Buy |
| Bollinger Bands (100): | (44.4 - 52) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.68 | Buy |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | 289999 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.8 - 41.14) | Sell |
| Bollinger Bands (100): | (19.01 - 36.29) | Buy |
HRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.5 | Buy |
| 20-day SMA: | 43 | Buy |
| 50-day SMA: | 45.53 | Sell |
| 200-day SMA: | 52.43 | Sell |
| 8-day EMA: | 43.49 | Buy |
| 20-day EMA: | 43.48 | Buy |
| 50-day EMA: | 45.15 | Sell |
| 200-day EMA: | 50.42 | Sell |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.86 | Sell |
| 20-day SMA: | 38.54 | Sell |
| 50-day SMA: | 35.24 | Buy |
| 200-day SMA: | 19.17 | Buy |
| 8-day EMA: | 35.64 | Buy |
| 20-day EMA: | 24.68 | Buy |
| 50-day EMA: | 12.87 | Buy |
| 200-day EMA: | 3.71 | Buy |
H&R Block, Inc. Earnings Growth & HRB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.52 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.15 per share.
H&R Block, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||